欧洲新闻T细胞和NK细胞接合双特异性抗体 英语_John.docx

QYResearch|market@|

EuropeanMarketforT-CellandNK-CellEngagingBispecificAntibodiesProjectedtoGrowat41%CAGRto2030

Geneva,Switzerland—December10,2024

EuropeanT-CellNK-CellEngagingBispecificAntibodiesMarketSize(€Million),2024-2030

TheEuropeanmarketforT-CellNK-CellEngagingBispecificAntibodieswasvaluedat€255.3millionintheyear2024andisprojectedtoreacharevisedsizeof€2006.1millionby2030,growingataCAGRof41.0%duringtheforecastperiod.

EuropeanT-CellNK-CellEngagingBispecificAntibodiesTop20PlayersRankingandMarketShare(Rankingisbasedontherevenueof2023,continuallyupdated)

·Amgen(UnitedStates)

·Immunocore(UnitedKingdom)

·JohnsonJohnson(UnitedStates)

·Roche(Switzerland)

·Pfizer(UnitedStates)

·AbbVie(UnitedStates)

·MacroGenics(UnitedStates)

·Regeneron(UnitedStates)

·GEMoaBMonoclonals(Germany)

·Zymeworks(Canada)

·SutroBiopharma(UnitedStates)

·Sotio(CzechRepublic)

·RevitopeOncology(UnitedStates)

·Genmab(Denmark)

3.T-CellNK-CellEngagingBispecificAntibodies,EuropeanMarketSize,SplitbyRegion

T-CellNK-CellEngagingBispecificAntibodies,EuropeanMarketSize,SplitbyProductSegment

5.T-CellNK-CellEngagingBispecificAntibodies,EuropeanMarketSize,SplitbyApplicationSegment

BasedonorincludesresearchfromQYResearch:GlobalandEuropeanT-CellNK-CellEngagingBispecificAntibodiesMarketReport2024-2030

RelatedMarketReportsFromQYResearch

QYResearchReleasesComprehensiveMarketReportsontheT-CellNK-CellEngagingBispecificAntibodiesMarket,asshowninthelinksbelow.Thesereportsprovideanin-depthanalysisofthecurrentmarketlandscape,keytrends,andfuturegrowthopportunities.

T-CellNK-CellEngagingBispecificAntibodies-GlobalMarketShareandRanking,OverallSalesandDemandForecast2024-2030

reports/3383572/t-cell---nk-cell-engaging-bispecific-antibodies

GlobalT-Cell